Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATALEE
NCT03701334Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- Dec 2018
- Primary completion
- May 2030
- Countries
- 20
01
Overview
A Phase 3 trial of ribociclib in breast cancer, sponsored by Novartis. Started Dec 2018; status: active, not recruiting.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03701334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701334.